Â鶹´«Ã½

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

Yesterday
Simply Wall St16:26 19-Sept-24
TipRanks06:25 19-Sept-24
Pharmaceutical Technology01:43 19-Sept-24
In the last 7 days
GlobeNewswire (Press Release)15:02 18-Sept-24
International Financing Review02:25 14-Sept-24
ENDPOINTS00:56 14-Sept-24
Law36023:56 13-Sept-24
TipRanks22:07 13-Sept-24
GlobeNewswire (Press Release)16:32 13-Sept-24
Valneva (Press Release)06:08 13-Sept-24
In the last month
PMLiVE21:32 6-Sept-24
GlobeNewswire (Press Release)02:11 5-Sept-24
ENDPOINTS05:38 4-Sept-24
Benzinga04:41 4-Sept-24
Benzinga01:16 4-Sept-24
Scrip Pharma Intelligence00:53 4-Sept-24
Biopharma Reporter23:22 3-Sept-24
Zacks23:04 3-Sept-24
TipRanks20:33 3-Sept-24
Clinical Trials Arena20:30 3-Sept-24
FierceBiotech19:04 3-Sept-24
pharmaphorum18:41 3-Sept-24
Valneva (Press Release)14:59 3-Sept-24
DGAP00:10 21-Aug-24
The Scotsman13:54 20-Aug-24
view more headlines
19 Sept 16:26

Valneva News

Latest news on Valneva, a French biotech company that develops and commercialises vaccines for infectious diseases.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.